GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ULTA · May 3, 2025

Ulta Beauty, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001558370-25-008243General Corporate
Capex intensity35thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

2.77% · OPTIONAL · VALID

Operating cash generation50thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

7.72% · OPTIONAL · VALID

Revenue growth40thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

4.49% · CORE · VALID

Gross margin45thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

39.12% · CORE · VALID

Operating margin40thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

14.11% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History62 statesSelf-history eligible
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
3.31%
Current
2.77%
Delta
-0.54%
Cash Generation Decreased
Previous
11.85%
Current
7.72%
Delta
-4.13%
Growth Increased
Previous
0.79%
Current
4.49%
Delta
3.71%
Margin Increased
Previous
38.84%
Current
39.12%
Delta
0.28%
Profitability Increased
Previous
13.85%
Current
14.11%
Delta
0.25%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.